- Supported exchanges /
- ST /
- ALZ.ST
Alzinova AB (ALZ ST) stock market data APIs
Alzinova AB (publ), a biopharmaceutical company, develops immunotherapies treatment for Alzheimer's disease in Sweden. Its lead product candidate is ALZ-101, an active therapeutic oligomer-specific vaccine for the treatment of Alzheimer's disease, which has completed part A of phase 1b study; and ALZ-201, a monoclonal antibody that neutralizes the toxic oligomers. The company is developing a humanized version of ALZ-201 in patients with Alzheimer's disease that is in phase 1 clinical study. The company was incorporated in 2011 and is based in Mölndal, Sweden.
Alzinova AB Financial Data Overview
| 3.43 | |
| 3.43 | |
| - | |
| 3.87 | |
| 4.04 | |
| 0.95-4.62 | |
| 330 M | |
| 89 166 K | |
| 14 922 K | |
| -0.0469 | |
| 1.229 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Alzinova AB Fundamental Data is available in our Financial Data APIs
- Net Revenue 14 922 K
- EBITDA 0
- Earnings Per Share -0.34
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Alzinova AB Earnings via APIs
- Latest Release 2024-11-14
- EPS/Forecast NaN
Get Alzinova AB End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
